SENATE FLOOR VERSION - HB2424 SFLR Page 1
(Bold face denotes Committee Amendments) 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
SENATE FLOOR VERSION
April 13, 2023
ENGROSSED HOUSE
BILL NO. 2424 By: May of the House
and
Stephens of the Senate
An Act relating to opioid antagonists; amending 63
O.S. 2021, Section 1 -2506.2, which relates to
prescription of opioid antagonists to family members;
replacing naloxone with opioid antagonist; amending
63 O.S. 2021, Section 2 -312.2, which relates to the
sale or dispensation of naloxone; removing naloxone
and replacing it with opioid antagonist; and
providing an effective d ate.
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTION 1. AMENDATORY 63 O.S. 2021, Section 1 -2506.2, is
amended to read as follows:
Section 1-2506.2 A. Upon request, a provider may prescribe an
opiate opioid antagonist to an individual for use by that individual
when encountering a family member exhibiting signs of an opiate
opioid overdose.
B. When an opiate opioid antagonist is prescribed in accordance
with subsection A of this section, the provider shall provide:
1. Information on how to spot symptoms of an overdose;
2. Instruction in basic resuscitation techniques;
SENATE FLOOR VERSION - HB2424 SFLR Page 2
(Bold face denotes Committee Amendments) 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
3. Instruction on proper naloxone opioid antagonist
administration; and
4. The importance of calling 911 nine-one-one (911) for help.
C. Any family member administering an opiate opioid antagonist
in a manner consistent with addressing opiate opioid overdose shall
be covered under the Good Samaritan Act.
D. Any provider prescribing o r administering an opiate opioid
antagonist in a manne r consistent with addressing opiate opioid
overdose shall be covered under the Good Samaritan Act.
SECTION 2. AMENDATORY 63 O.S. 2021, Section 2 -312.2, is
amended to read as follows:
Section 2-312.2 Naloxone, also known as Narcan , or any of its
generic equivalents Any opioid antagonist that is approved by the
United States Food and Drug Admini stration may be dispensed or sold
by a pharmacy without a prescription; provided, however, it shall be
dispensed or sold only by, or under t he supervision of, a licensed
pharmacist. Naloxone An opioid antagonist may be prescribed and
dispensed by a licens ed pharmacist; provided, however, it shall be
dispensed only by, or under the supervision of, a licensed
pharmacist. No dispensing protocol shall be required.
SECTION 3. This act shall become effective November 1, 2023.
COMMITTEE REPORT BY: COMMITTEE ON HEALTH AND HUMAN SERVICES
April 13, 2023 - DO PASS